Nuwellis, Inc. To Announce Second Quarter 2022 Financial Results on August 9, 2022
Nuwellis, Inc. (NASDAQ: NUWE) will release its Q2 2022 financial results on August 9, 2022, followed by a conference call and webcast at 9:00 AM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nuwellis, Inc. (NASDAQ: NUWE) will release its Q2 2022 financial results on August 9, 2022, followed by a conference call and webcast at 9:00 AM ET. The call aims to discuss the financial outcomes and provide a general business overview. Nuwellis focuses on developing the Aquadex SmartFlow® system for ultrafiltration therapy to assist patients with fluid overload. For additional details, visit the Investors page on their website.
Details
News Market Reaction – NUWE
The recorded move for NUWE in the trading session of this news was -1.72%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, July 14, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its second quarter 2022 financial results will be released on Tuesday, August 9, 2022. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview. To access the live webcast, please visit https://edge.media-server.com/mmc/p/frxpm437 [edge.media-server.com], or the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by registering through https://register.vevent.com/register/BIea28b3e149034b04b99b65da059db74a. An audio archive of the webcast will be available following the call on the Investors page at https://ir.nuwellis.com.
About Nuwellis
Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, MN, with a wholly-owned subsidiary in Ireland.
Investor Contacts:
George Montague, CFA
Chief Financial Officer, Nuwellis, Inc.
ir@nuwellis.com
Matt Bacso, CFA
Gilmartin Group LLC
Matt.bacso@gilmartinir.com
Media Contact:
Sarah Lundberg
Health+Commerce
sarahlundberg@healthandcommerce.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.